Frontiers in Immunology,
Год журнала:
2022,
Номер
13
Опубликована: Апрель 5, 2022
Diet
is
an
important
lifestyle
factor
that
known
to
contribute
in
the
development
of
human
disease.
It
well
established
poor
diet
plays
active
role
exacerbating
metabolic
diseases,
such
as
obesity,
diabetes
and
hypertension.
Our
understanding
how
immune
system
drives
chronic
inflammation
disease
pathogenesis
has
evolved
recent
years.
However,
contribution
dietary
factors
inflammatory
conditions
bowel
disease,
multiple
sclerosis
arthritis
remain
poorly
defined.
A
western
been
associated
pro-inflammatory,
contrast
traditional
patterns
are
being
anti-inflammatory.
This
may
be
due
direct
effects
nutrients
on
cell
function.
also
affect
composition
function
gut
microbiota,
which
consequently
affects
immunity.
In
animal
models
modulate
gastrointestinal
tract
other
peripheral
sites.
Despite
limitations
models,
there
now
emerging
evidence
show
anti-inflammatory
translate
diseases.
appropriately
designed,
larger
clinical
studies
must
conducted
confirm
therapeutic
benefit
therapy.
The
field
of
microbiome
research
has
evolved
rapidly
over
the
past
few
decades
and
become
a
topic
great
scientific
public
interest.
As
result
this
rapid
growth
in
interest
covering
different
fields,
we
are
lacking
clear
commonly
agreed
definition
term
"microbiome."
Moreover,
consensus
on
best
practices
is
missing.
Recently,
panel
international
experts
discussed
current
gaps
frame
European-funded
MicrobiomeSupport
project.
meeting
brought
together
about
40
leaders
from
diverse
areas,
while
more
than
hundred
all
world
took
part
an
online
survey
accompanying
workshop.
This
article
excerpts
outcomes
workshop
corresponding
embedded
short
historical
introduction
future
outlook.
We
propose
based
compact,
clear,
comprehensive
description
provided
by
Whipps
et
al.
1988,
amended
with
set
novel
recommendations
considering
latest
technological
developments
findings.
clearly
separate
terms
microbiota
provide
discussion
composition
microbiota,
heterogeneity
dynamics
microbiomes
time
space,
stability
resilience
microbial
networks,
core
microbiomes,
functionally
relevant
keystone
species
as
well
co-evolutionary
principles
microbe-host
inter-species
interactions
within
microbiome.
These
broad
definitions
suggested
unifying
concepts
will
help
to
improve
standardization
studies
future,
could
be
starting
point
for
integrated
assessment
data
resulting
transfer
knowledge
basic
science
into
practice.
Furthermore,
standards
important
solving
new
challenges
associated
anthropogenic-driven
changes
planetary
health,
which
understanding
might
play
key
role.
Video
Abstract.
Cells,
Год журнала:
2023,
Номер
12(1), С. 184 - 184
Опубликована: Янв. 2, 2023
Immune
cells
and
commensal
microbes
in
the
human
intestine
constantly
communicate
with
react
to
each
other
a
stable
environment
order
maintain
healthy
immune
activities.
system-microbiota
cross-talk
relies
on
complex
network
of
pathways
that
sustain
balance
between
tolerance
immunogenicity.
Probiotic
bacteria
can
interact
stimulate
intestinal
microflora
modulate
specific
functions
homeostasis.
Growing
evidence
shows
probiotic
present
important
health-promoting
immunomodulatory
properties.
Thus,
use
probiotics
might
represent
promising
approach
for
improving
system
So
far,
few
studies
have
been
reported
beneficial
modulatory
effect
probiotics.
However,
many
others,
which
are
mainly
focused
their
metabolic/nutritional
properties,
published.
Therefore,
mechanisms
behind
interaction
host
only
partially
described.
The
review
aims
collect
summarize
most
recent
scientific
results
resulting
implications
how
improve
functions.
Hence,
description
currently
known
is
provided.
Seminars in Immunopathology,
Год журнала:
2020,
Номер
42(1), С. 75 - 93
Опубликована: Фев. 1, 2020
Abstract
Worldwide
300
million
children
and
adults
are
affected
by
asthma.
The
development
of
asthma
is
influenced
environmental
other
exogenous
factors
synergizing
with
genetic
predisposition,
shaping
the
lung
microbiome
especially
during
birth
in
very
early
life.
healthy
microbial
composition
characterized
a
prevalence
bacteria
belonging
to
phyla
Bacteroidetes
,
Actinobacteria
Firmicutes
.
However,
viral
respiratory
infections
associated
an
abundance
Proteobacteria
genera
Haemophilus
Moraxella
young
adult
asthmatics.
This
dysbiosis
supports
activation
inflammatory
pathways
contributes
bronchoconstriction
bronchial
hyperresponsiveness.
Exogenous
can
affect
natural
microbiota
positively
(farming
environment)
or
negatively
(allergens,
air
pollutants).
It
evident
that
also
gut
has
high
influence
on
pathogenesis.
Antibiotics,
antiulcer
medications,
drugs
severely
impair
as
well
microbiota.
Resulting
reduced
diversity
dysregulate
bidirectional
crosstalk
across
gut-lung
axis,
resulting
hypersensitivity
hyperreactivity
food
allergens.
Efforts
undertaken
reconstitute
immune
balance
probiotics
engineered
bacteria,
but
results
from
human
studies
do
not
yet
support
their
efficacy
prevention
treatment.
Overall,
seem
be
critical
causes
increased
emergence
Nutrients,
Год журнала:
2021,
Номер
13(3), С. 886 - 886
Опубликована: Март 9, 2021
Infectious
diseases
and
infections
remain
a
leading
cause
of
death
in
low-income
countries
major
risk
to
vulnerable
groups,
such
as
infants
the
elderly.
The
immune
system
plays
crucial
role
susceptibility,
persistence,
clearance
these
infections.
With
70–80%
cells
being
present
gut,
there
is
an
intricate
interplay
between
intestinal
microbiota,
epithelial
layer,
local
mucosal
system.
In
addition
responses
it
increasingly
recognized
that
gut
microbiome
also
affects
systemic
immunity.
Clinicians
are
more
using
increased
knowledge
about
complex
interactions
system,
microbiome,
human
pathogens.
now
well-recognized
impact
nutrition
on
composition
microbiota
elucidates
can
play
improving
health.
This
review
describes
mechanisms
involved
maintaining
balance
health,
response,
immunity,
linking
this
infectious
throughout
life,
highlights
disease
prevention
treatment.
Frontiers in Microbiology,
Год журнала:
2023,
Номер
13
Опубликована: Янв. 12, 2023
Gut-microbial
butyrate
is
a
short-chain
fatty
acid
(SCFA)
of
significant
physiological
importance
than
the
other
major
SCFAs
(acetate
and
propionate).
Most
producers
belong
to
Clostridium
cluster
phylum
Firmicutes,
such
as
Faecalibacterium
,
Roseburia
Eubacterium
Anaerostipes
Coprococcus
Subdoligranulum
Anaerobutyricum
.
They
metabolize
carbohydrates
via
butyryl-CoA:
acetate
CoA-transferase
pathway
kinase
terminal
enzymes
produce
most
butyrate.
Although,
in
minor
fractions,
amino
acids
can
also
be
utilized
generate
glutamate
lysine
pathways.
Butyrogenic
microbes
play
vital
role
various
gut-associated
metabolisms.
Butyrate
used
by
colonocytes
energy,
stabilizes
hypoxia-inducible
factor
maintain
anaerobic
environment
gut,
maintains
gut
barrier
integrity
regulating
Claudin-1
synaptopodin
expression,
limits
pro-inflammatory
cytokines
(IL-6,
IL-12),
inhibits
oncogenic
pathways
(Akt/ERK,
Wnt,
TGF-β
signaling).
Colonic
shape
microbial
community
secreting
anti-microbial
substances,
cathelicidins,
reuterin,
β-defensin-1,
homeostasis
releasing
anti-inflammatory
molecules,
IgA,
vitamin
B,
molecules.
Additionally,
producers,
anti-carcinogenic
metabolites,
shikimic
precursor
conjugated
linoleic
acid.
In
this
review,
we
summarized
significance
butyrate,
critically
examined
relevance
contextualized
their
therapeutics.
Nutrients,
Год журнала:
2020,
Номер
12(6), С. 1718 - 1718
Опубликована: Июнь 8, 2020
The
severe
acute
respiratory
syndrome
coronavirus
2
(Sars-CoV-2)
global
pandemic
is
a
devastating
event
that
causing
thousands
of
victims
every
day
around
the
world.
One
main
reasons
great
impact
disease
2019
(COVID-19)
on
society
its
unexpected
spread,
which
has
not
allowed
an
adequate
preparation.
scientific
community
fighting
against
time
for
production
vaccine,
but
it
difficult
to
place
safe
and
effective
product
market
as
fast
virus
spreading.
Similarly,
drugs
can
directly
interfere
with
viral
pathways,
their
times
are
long,
despite
efforts
made.
For
these
reasons,
we
analyzed
possible
role
non-pharmacological
substances
such
supplements,
probiotics,
nutraceuticals
in
reducing
risk
Sars-CoV-2
infection
or
mitigating
symptoms
COVID-19.
These
could
have
numerous
advantages
current
circumstances,
generally
easily
available,
negligible
side
effects
if
administered
at
already
used
tested
dosages.
Large
evidence
supports
benefits
some
bacterial
molecular
products
may
exert
immune
response
viruses.
also
regulatory
systemic
inflammation
endothelial
damage,
two
crucial
aspects
However,
there
no
specific
data
rigorous
clinical
trials
should
be
conducted
confirm
putative
diet
supplementation,
pandemic.
Frontiers in Immunology,
Год журнала:
2021,
Номер
12
Опубликована: Фев. 24, 2021
COVID-19
is
an
infectious
disease
caused
by
the
Severe
Acute
Respiratory
Syndrome
Coronavirus-2
(SARS-CoV-2),
and
according
to
World
Health
Organization
(WHO),
date,
SARS-CoV-2
has
already
infected
more
than
91.8
million
people
worldwide
with
1,986,871
deaths.
This
virus
affects
mainly
respiratory
system,
but
gastrointestinal
tract
(GIT)
also
a
target,
meanwhile
was
detected
in
oesophagus,
stomach,
duodenum,
rectum,
fecal
samples
from
patients.
Prolonged
GIT
manifestations
COVID-19,
diarrhea,
were
correlated
decreased
richness
diversity
of
gut
microbiota,
immune
deregulation
delayed
clearance.
So,
bidirectional
interactions
between
mucosa
known
as
gut-lung
axis,
are
supposed
be
involved
healthy
or
pathologic
responses
SARS-CoV-2.
In
accordance,
intestinal
dysbiosis
associated
increased
mortality
other
infections,
due
exacerbated
inflammation
regulatory
anti-inflammatory
mechanisms
lungs
gut,
pointing
this
important
relationship
both
mucosal
compartments.
Therefore,
since
mucous
membranes
tracts
affected,
addition
inflammation,
it
plausible
assume
that
adjunctive
therapies
based
on
modulation
microbiota
re-establishment
eubiosis
conditions
could
therapeutic
approach
for
constraining
harmful
consequences
COVID-19.
Then,
review,
we
summarized
studies
showing
persistence
system
related
digestive
manifestations,
literature
demonstrating
nasopharyngeal,
pulmonary
Lastly,
showed
potential
beneficial
role
probiotic
administration
discuss
possible
probiotics
therapy
infection.
npj Science of Food,
Год журнала:
2020,
Номер
4(1)
Опубликована: Окт. 5, 2020
Abstract
COVID-19
is
a
pandemic
disease
caused
by
the
novel
coronavirus
severe
acute
respiratory
syndrome
2
(SARS-CoV-2).
This
new
viral
infection
was
first
identified
in
China
December
2019,
and
it
has
subsequently
spread
globally.
The
lack
of
vaccine
or
curative
treatment
for
necessitates
focus
on
other
strategies
to
prevent
treat
infection.
Probiotics
consist
single
mixed
cultures
live
microorganisms
that
can
beneficially
affect
host
maintaining
intestinal
lung
microbiota
play
major
role
human
health.
At
present,
good
scientific
evidence
exists
support
ability
probiotics
boost
immunity,
thereby
preventing
colonization
pathogens
reducing
incidence
severity
infections.
Herein,
we
present
clinical
studies
use
probiotic
supplementation
tract
These
data
lead
promising
benefits
risk
COVID-19.
Further
should
be
conducted
assess
combat